iiinova — where your digital self keeps evolving

REMEDi4ALL @remedi4all.bsky.social · 01/10/2026

🔍 Did you know REMEDi4ALL has published 30+ open-access papers on drug repurposing? 📚From AI-powered tools and policy research to rare diseases and real-world case studies, explore the latest findings: loom.ly/TxjYWsc

000

REMEDi4ALL @remedi4all.bsky.social · 28/09/2026

📢 Build the knowledge and practical skills to help advance promising drug repurposing opportunities towards patient impact! Join the REMEDi4ALL Repurposing Bootcamp for Patient Representatives on 10–11 June 2027 in Barcelona. 🔗 Apply here before 16 October: loom.ly/H2FxxGE

000

REMEDi4ALL @remedi4all.bsky.social · 25/09/2026

💊 Yesterday at #RExPO26 in Berlin, Patricia Vandamme of the Anticancer Fund presented the session “REMEDi4ALL – Building a sustainable platform, strengthening the Drug Repurposing ecosystem”. 👉 Read the session abstract here: loom.ly/yR3jKTw

000

REMEDi4ALL @remedi4all.bsky.social · 16/09/2026

This year’s REMEDi4ALL Hackathon brought together 15 early-career researchers, experts and patient representatives to explore drug repurposing opportunities for three rare neurodevelopmental disorders. Thank you to everyone involved! 👉 Read the full event summary here: loom.ly/czEAwGk

010

REMEDi4ALL @remedi4all.bsky.social · 15/09/2026

Join us at the #REMEDi4ALL Repurposing Bootcamp in Barcelona on 10-11 June 2027! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply now! 🔗 loom.ly/H2FxxGE

000

REMEDi4ALL @remedi4all.bsky.social · 11/09/2026

👏 That's a wrap on the 2026 REMEDi4ALL Hackathon! 🏆 Congratulations to the winning team, representing SATB2-associated syndrome, and to all teams for their excellent work, dedication and collaborative spirit throughout the hackathon. Stay tuned for more insights and highlights!

000

REMEDi4ALL @remedi4all.bsky.social · 09/09/2026

💻 The REMEDi4ALL Hackathon continues in Montserrat, Spain! Participants have been diving deep into databases, exploring and prioritising potential drug repurposing candidates for neurodevelopmental disorders. 💫 Stay tuned for more insights from the Hackathon this week!

000

REMEDi4ALL @remedi4all.bsky.social · 07/09/2026

💊 The REMEDi4ALL #Hackathon is underway in Montserrat! Following a visit to the Montserrat Monastery, participants have explored drug repurposing through REPURPOLIS and computational sessions. Next up: patient engagement, TPPs, eHTA and routes to market. #REMEDi4ALL

020

REMEDi4ALL @remedi4all.bsky.social · 03/09/2026

📄 A recent article from Inside Precision Medicine highlights REMEDi4ALL’s work with partners EURORDIS and Fraunhofer ITMP to support researchers and patient organisations across the repurposing pathway. 🔗 loom.ly/YVW3Zp8

010

REMEDi4ALL @remedi4all.bsky.social · 01/09/2026

Are you a patient representative curious about #DrugRepurposing? Join us at the #REMEDi4ALL Repurposing Bootcamp in Barcelona on 10-11 June 2027! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply now! 🔗 loom.ly/H2FxxGE

011

REMEDi4ALL @remedi4all.bsky.social · 25/08/2026

📢 New REMEDi4ALL publication! A new study presents a scalable drug repurposing approach that uses cell painting and morphological profiling to identify potential antiviral candidates to support future antiviral research and pandemic preparedness! 🔗 loom.ly/2CtU5YE

000

REMEDi4ALL @remedi4all.bsky.social · 18/08/2026

💊 The MOI-A study is investigating the potential of losartan as a treatment for older adolescents and adults living with this rare genetic bone disorder. As Alessandra Tolaccia of OIFE explains, the potential impact for adult patients is deeply personal. 👉 Learn more: loom.ly/uaJ_YgA

000

REMEDi4ALL @remedi4all.bsky.social · 17/08/2026

🌎 REMEDi4ALL Scientific Lead Don Lo contributed to an FDA-supported meeting on advancing drug repurposing opportunities towards regulatory approval and patient access. Don emphasised, “Translation is a team sport.” Progress requires coordinated expertise across sectors. 🔗https://loom.ly/EEind5M

000

REMEDi4ALL @remedi4all.bsky.social · 12/08/2026

Join the 'Medicines Reimagined' Forum, where enthusiasts and experts in drug repurposing unite! Connect, collaborate, share insights, and explore the challenges and successes in the #DrugRepurposing field. 👉 Join the dialogue today: remedi4all.org/stakeholder-forum

000

REMEDi4ALL @remedi4all.bsky.social · 06/08/2026

💊 Build your knowledge of drug repurposing with the REMEDi4ALL Digital Academy. This free online learning platform offers accessible, expert-led training for researchers, patient organisations, industry representatives. 👉 Start learning today: loom.ly/6FQD_TQ

001

REMEDi4ALL @remedi4all.bsky.social · 30/07/2026

🌍 On #MSDWorldDay, REMEDi4ALL stands with families affected by multiple sulfatase deficiency. Our demonstrator project is investigating whether tazarotene could be repurposed as a treatment for MSD, working closely with patient champion Alan Finglas. 👉Learn more: loom.ly/rfokBf8

000

REMEDi4ALL @remedi4all.bsky.social · 29/07/2026

💊 The MOI-A study, a REMEDi4ALL demonstrator project, is investigating the potential of losartan as a treatment for older adolescents and adults living with this rare genetic bone disorder. 👉 Learn more and find out how patients and families can get involved here: loom.ly/uaJ_YgA

001

REMEDi4ALL @remedi4all.bsky.social · 27/07/2026

💊 On 12–13 May 2026, REMEDi4ALL and Beacon for Rare Diseases brought together the international drug repurposing community in Brussels for #iDR26. Want to revisit the conference? The #iDR26 Conference Hub is now available here:

000

REMEDi4ALL @remedi4all.bsky.social · 21/07/2026

🎥 Missed our webinar, Understanding the Value of Your Repurposed Medicine? You can now watch the full recording through the REMEDi4ALL Digital Academy. 🎓 Watch the webinar and start learning for free today: loom.ly/IeBJ9No

011

REMEDi4ALL @remedi4all.bsky.social · 15/07/2026

⏰ Final reminder! Join our webinar on Understanding the Value of Your Repurposed Medicine. Hear from Prof. Zoltán Kaló, Diana Kwast-Hoekstra and Dalma Hosszú on HTA, patient evidence and how early planning can strengthen drug repurposing. 👉 Register: loom.ly/P2DRFRA

000

REMEDi4ALL @remedi4all.bsky.social · 13/07/2026

Congratulations to Prof. Zoltán Kaló, co-founder of REMEDi4ALL partner Syreon Research Institute, on his appointment as Director General of Hungary’s National Health Insurance Fund. We look forward to continuing our collaboration through the REMEDi4ALL Policy Board. 🔗 loom.ly/oSxOKDM

000

REMEDi4ALL @remedi4all.bsky.social · 09/07/2026

💊 Repurposing of losartan for the treatment of Osteogenesis Imperfecta (OI) One of REMEDi4ALL’s demonstrator projects is running a clinical trial investigating whether losartan could offer benefits for adolescents and adults with OI. 👉 Learn how to get involved here: loom.ly/uaJ_YgA

000

REMEDi4ALL @remedi4all.bsky.social · 08/07/2026

📣 Join experts from the Syreon Research Institute for an insightful webinar exploring Health Technology Assessment (HTA), Early HTA, and the role of patient preference evidence in the development and evaluation of repurposed medicines. 👉 Register here: loom.ly/P2DRFRA

000

REMEDi4ALL @remedi4all.bsky.social · 02/07/2026

🎬 The #iDR26 highlight reel is here! Hear from participants as they reflect on the importance of bringing the global drug repurposing community together to exchange ideas and address the challenges of delivering repurposed medicines to the patients who need them. 🔗 More: loom.ly/IGWmuZQ

000

REMEDi4ALL @remedi4all.bsky.social · 30/06/2026

📝 Read our recent interview with REMEDi4ALL iDR26 poster first author Nikoleta Efthymiopoulou We spoke with her about the research and her experience presenting a poster exploring the prevalence and impact of repurposing across modern drug development. 🔗 Read more: loom.ly/52o4MUM

000

REMEDi4ALL @remedi4all.bsky.social · 29/06/2026

000

REMEDi4ALL @remedi4all.bsky.social · 25/06/2026

000

REMEDi4ALL @remedi4all.bsky.social · 22/06/2026

000

REMEDi4ALL @remedi4all.bsky.social · 17/06/2026

📚New REMEDi4ALL publication in Nature Reviews Drug Discovery looks at lessons from the EU repurposing pilot under STAMP — and how collaboration can help bridge the gap between research and approval. Read more➡️: loom.ly/UqrNI8k #DrugRepurposing #EUHealth #STAMP

010

REMEDi4ALL @remedi4all.bsky.social · 15/06/2026

000

REMEDi4ALL @remedi4all.bsky.social · 12/06/2026

🧪 New publication from REMEDi4ALL researchers! Aligning methods across labs improves the reliability of drug repurposing for pancreatic cancer. Researchers confirmed a consistent effect of combining two existing medicines and enhanced chemotherapy response. 📖 Read more: loom.ly/IATG6dg

000

REMEDi4ALL @remedi4all.bsky.social · 08/06/2026

Are you a patient representative curious about #DrugRepurposing? Join us at the #REMEDi4ALL Repurposing Bootcamp in Paris, 2-3 November 2026! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply before 10 June here: 🔗 loom.ly/GVUxULs

000

REMEDi4ALL @remedi4all.bsky.social · 04/06/2026

🌐 Ahead of #iDR26, the REMEDi4ALL Funders Network met in Brussels, bringing together funders & policymakers. Discussions explored innovative #DrugRepurposing funding models, policy & regulatory conditions, and new tools supporting collaboration! 🔗Learn more: loom.ly/CxpCqYc

010

REMEDi4ALL @remedi4all.bsky.social · 03/06/2026

The Medicines Reimagined Stakeholder Forum brings together the diverse voices driving innovation in drug repurposing. Whether you're an experienced stakeholder or new to the field, this community is for you! 👉 Join the forum today: remedi4all.org/stakeholder-forum

000

REMEDi4ALL @remedi4all.bsky.social · 01/06/2026

000

REMEDi4ALL @remedi4all.bsky.social · 25/05/2026

Join the #REMEDi4ALL Drug Repurposing Bootcamp for Patient Representatives and lead the way in innovative treatment strategies! This training equips patient representatives with the essential knowledge and tools to drive innovation through drug repurposing Apply now! 🔗 loom.ly/GVUxULs

000

REMEDi4ALL @remedi4all.bsky.social · 19/05/2026

🔔 Last chance to apply for the REMEDi4ALL Hackathon! Applications close tomorrow (20 May, 23:59 CEST). Join multidisciplinary teams, get expert mentoring & work on impactful drug repurposing challenges. 📩 Apply now: loom.ly/lf9rypQ #DrugRepurposing #Hackathon

020

REMEDi4ALL @remedi4all.bsky.social · 18/05/2026

🎉That's a wrap on #iDR26! Over two packed days in Brussels, we brought together over 250 attendees from the global repurposing community for inspiring talks, panels, posters, and networking. Thanks again to our speakers and attendees! Read our highlights and takeaways here: loom.ly/IGWmuZQ

022

REMEDi4ALL @remedi4all.bsky.social · 13/05/2026

🎉 That's a wrap on the final day of #iDR26! Check out some of our highlights from today below! Thank you for joining us, for your active engagement, and for your valuable contributions. Special thanks to all speakers, moderators, panellists, sponsors, and partners who helped make #iDR26 possible.

020

REMEDi4ALL @remedi4all.bsky.social · 13/05/2026

💊 We are ready to kick off Day 2 of the International Drug Repurposing Conference #iDR26! We have an amazing agenda of Community and Industry track sessions and plenary sessions focusing on patient-centricity and the future of repurposing! 👉 Find the full agenda here: loom.ly/RA5Yss4

010

REMEDi4ALL @remedi4all.bsky.social · 12/05/2026

It's been an amazing first day at #iDR26, navigating the future of drug repurposing for patient benefit in Brussels! See you tomorrow for more track and plenary sessions! 👉 Check out some of the highlights from today's session below and find full agenda here: loom.ly/RA5Yss4

020

REMEDi4ALL @remedi4all.bsky.social · 12/05/2026

📮 💊From a repurposed post office in the heart of Brussels, the drug repurposing community came together to do what it does best: connect across disciplines, share ideas and turn collective expertise into action. Thank you to everyone who joined us. Bring on Day 2!

040

REMEDi4ALL @remedi4all.bsky.social · 12/05/2026

#iDR26 has officially begun at the historic Maison de la Poste in Brussels! It's amazing to be here together with the diverse repurposing community exploring the future of drug repurposing! 👉 Discover the full agenda here: loom.ly/RA5Yss4

010

REMEDi4ALL @remedi4all.bsky.social · 08/05/2026

🚨 Last chance to register for #iDR26 in Brussels next week! We're looking forward to welcoming you to Brussels for two inspiring days focused on shaping the future of drug repurposing. 🎟️ Don't have your ticket yet? A few places remain - register here: loom.ly/ToR-dtw

000

REMEDi4ALL @remedi4all.bsky.social · 07/05/2026

A new article in Nature Reviews Drug Discovery, inspired by discussions at previous International Drug Repurposing Conferences (iDR), explores how we can make the most of the potential of drug repurposing. 🔗 Read the article: bit.ly/4eyNFjq 🎟️ Register for iDR26: remedi4all.org/iDR26

031

REMEDi4ALL @remedi4all.bsky.social · 07/05/2026

📣 Introducing the final plenary session at #iDR26: The future of drug repurposing! At the closing session of #iDR26, we will explore potential challenges and our hope for the future of drug repurposing. 📅 12–13 May 2026, Brussels 🔗 Learn more and register here: loom.ly/9dw7qdk

000

REMEDi4ALL @remedi4all.bsky.social · 06/05/2026

⌛ Are you an early‑career researcher interested in drug repurposing? The REMEDi4ALL #Hackathon brings together multidisciplinary teams to learn from experts and explore hands-on how existing medicines can reach patients. ➡️Applications close soon – apply now: loom.ly/2V3NnfI

010

REMEDi4ALL @remedi4all.bsky.social · 05/05/2026

We're excited to welcome you to Brussels next week for #iDR26 - the 2026 International Drug Repurposing Conference! 🎟️ Final tickets are available: loom.ly/ToR-dtw Don't miss the opportunity to take part in this unique conference programme! 👉 Full agenda here: loom.ly/RA5Yss4

020

REMEDi4ALL @remedi4all.bsky.social · 05/05/2026

🔎 How can we shape a better drug repurposing policy landscape? New REMEDi4ALL work in Health Policy OPEN uses multi‑stakeholder input to prioritise barriers and inform actionable reforms. Join #iDR26 to learn more🎟️: loom.ly/gh97s9k REMEDi4ALL summary here➡️: loom.ly/IdIBEak

020

REMEDi4ALL @remedi4all.bsky.social · 04/05/2026

Plenary Session I at #iDR26! At the first session of iDR26, we'll dive into the innovative developments in the field of drug repurposing and meet the patient groups, funders, and regulators driving that change. 📅 12–13 May 2026, Brussels 🔗 Learn more and register here: loom.ly/9dw7qdk

020